Epigenetic inhibitors as a promising new antimalarial intervention strategy? A new study identifies an inhibitor of gene regulation that specifically kills the malaria pathogen.

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study involving the University of Surrey.

Texas Children's Hospital and The University of Texas MD Anderson Cancer Center have announced a transformational collaboration dedicated solely to pediatric cancer care.

A Kentucky county nestled in the heart of Appalachia, where the opioid crisis has wreaked devastation for decades, spent $15,000 of its opioid settlement money on an ice rink.

Whether you're settling into your 60s or heading into your 90s, be careful when taking medicines, herbal preparations and supplements.

Preteens who spend more time on screens are more likely to develop manic symptoms years two-years later, according to a new study published in Social Psychiatry and Psychiatric Epidemiology.

The appointment of Mike Hampton and the launch of a Scientific Office position Sapio Sciences at the forefront of AI-driven lab informatics and drug discovery.

A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called cannabinoid hyperemesis syndrome.

Cardiac arrhythmias affect millions across the world and are responsible for a fifth of all deaths in the Netherlands.

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe.